Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

Fast facts about IAVI’s contributions to fighting Lassa fever in West Africa

September 11, 2025

IAVI has been developing emerging infectious disease (EID) vaccines for a range of priority pathogens, including Lassa virus, since 2018.

Read more

Features

Fast facts about the preclinical data supporting IAVI’s Marburg virus vaccine candidate

September 11, 2025

IAVI has been developing emerging infectious disease (EID) vaccines for a range of priority pathogens, including Marburg virus, since 2018.

Read more

Features

Frequently asked questions: Lassa fever

September 11, 2025

Learn more about Lassa virus, a zoonotic virus that causes severe hemorrhagic fever in humans.

Read more

Features

Frequently asked questions: Marburg virus disease

September 11, 2025

Learn more about Marburg virus, a filovirus that causes a severe hemorrhagic illness in humans.

Read more

Features

Frequently asked questions: Sudan virus disease

September 11, 2025

Learn more about Sudan virus, a filovirus that causes severe hemorrhagic illness in humans.

Read more

Features

IAVI mourns the passing of David Baltimore

September 8, 2025

Baltimore's Nobel Prize-winning work led to critical insights about HIV.

Read more

Features

TICAD9 thematic event: Unlocking the Potential of Vaccine R&D and Manufacturing Capabilities in Africa | TICAD9 テーマ別イベント:アフリカのワクチン研究開発・製造能⼒の可能性

August 4, 2025

Join us at a TICAD thematic event on August 22 either in-person or virtually | 8月22日に対面とオンライン配信にて開催

Read more

Features

IAVI announces first enrollment in tuberculosis epidemiology study

July 31, 2025

This study supports the preparation for late-stage tuberculosis (TB) vaccine efficacy trials by providing key epidemiological data.

Read more